The new Center for Molecular Cardiology (CMC), a member center of the Feinberg Cardiovascular Research Institute, seeks to be the premier molecular cardiology research center in the world. Led by Hossein Ardehali, MD/PhD, we look to be Feinberg’s home to physician-scientists and cardiologists working in cardiovascular disease. Our goal is to understand and develop novel therapies for devastating conditions such as heart failure and arrhythmias. Our center also focuses on cardiac regeneration and stem cell therapy.
Center Mission and Goals
The CMC looks to provide a comprehensive support system for our members and University colleagues. Our goals include:
- Grow and maintain a collaborative environment for cardiac scientists
- Expand the existing core facilities and instruments that are already available to the FCVRI members (such as hypoxic chamber, tissue cultures, qRT-PCR, animal surgery, echocardiography), and provide new additional services, based on the need of the Center members
- Develop a training program with opportunities for trainees to do research in cardiovascular disease, and present and publish their work
- Offer formalized mentoring to trainees and junior faculty
- Provide molecular cardiology services to University scientists (e.g., animal heart surgery, echocardiography, and invasive hemodynamic measurement)
- Support members in publication and funding efforts
Learn more about the work being done through our center via the links below.
To connect with our center, please contact Kari LeBeau.
Help our center reach our goals. Learn about the giving options available.
Our center has postdoctoral opportunities available. See the FCVRI Careers page for more information.